Form 8-K - Current report:
SEC Accession No. 0000896264-25-000144
Filing Date
2025-05-20
Accepted
2025-05-19 18:25:27
Documents
16
Period of Report
2025-05-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K usna-20250519.htm   iXBRL 8-K 52416
2 EX-10.1 a101usanahealthsciencesinc.htm EX-10.1 182181
3 EX-10.2 a102formofperformanceshare.htm EX-10.2 44842
4 EX-10.3 a103formofstockappreciatio.htm EX-10.3 46211
5 EX-10.4 a104formofrestrictedstocku.htm EX-10.4 47875
  Complete submission text file 0000896264-25-000144.txt   550135

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT usna-20250519.xsd EX-101.SCH 1776
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT usna-20250519_lab.xml EX-101.LAB 21629
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT usna-20250519_pre.xml EX-101.PRE 12504
18 EXTRACTED XBRL INSTANCE DOCUMENT usna-20250519_htm.xml XML 2732
Mailing Address 3838 WEST PARKWAY BLVD. 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336
Business Address 3838 WEST PARKWAY BLVD. SALT LAKE CITY UT 84120-6336 8019547100
USANA HEALTH SCIENCES INC (Filer) CIK: 0000896264 (see all company filings)

EIN.: 870500306 | State of Incorp.: UT | Fiscal Year End: 1228
Type: 8-K | Act: 34 | File No.: 001-35024 | Film No.: 25965486
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)